Alterations of GABA-mediated synaptic transmission in human epilepsy
- PMID: 3010675
Alterations of GABA-mediated synaptic transmission in human epilepsy
Abstract
Although animal models consistently indicate that gamma-amino-butyric acid (GABA) synaptic function (GABA levels, synthesis, uptake and/or receptors) is decreased in seizure states, there is little evidence to date in support of such a hypothesis for human epilepsy. This chapter presents the results of an in-depth study of the activity of the GABA-synthesizing enzyme L-glutamic acid decarboxylase (GAD) in brain tissue removed during neurosurgical resection for intractable epilepsy. The tissue studied is unique in that identified (by stereo EEG) foci were excised (rather than large blocks of tissue containing mixtures of foci and nonepileptic material) and compared with nonepileptic (stereo EEG and morphological definitions) tissue from the same patients. In patients in which there was no indication of a tumor, GAD activity in the foci was low in more than 50% of the patients examined. Furthermore, when the population distribution of GAD was compared in epileptic versus nonepileptic tissue fragments from all patients, the peak distribution of epileptic tissue fragments occurred at much lower GAD activities than for the nonepileptic fragments (0-20 versus 41-80 nmol CO2/mg protein X hr, respectively). A small subgroup of epileptic fragments occurred with a normal GAD distribution, indicating that the presence of an epileptic focus was not invariably associated with low GAD activity. When the low levels of GABA "A" binding sites in these epileptic tissue fragments are taken into consideration in combination with the low GAD levels, then it can be estimated that 60 to 70% of the present patient population had deficient GABAergic transmission in epileptic foci as compared to nonepileptic brain tissue from the same patients. It follows that the GABA hypothesis of human epilepsy is not an exclusive or unitary hypothesis, and some patients appear to have normally functioning GABA synapses (as assessed biochemically) in epileptogenic areas. Thus, other neurotransmitter and neurohumoral systems certainly play a role in the epileptic process.
Similar articles
-
[Amino acids in human epileptogenic foci].Neurochirurgie. 1986;32(4):365-8. Neurochirurgie. 1986. PMID: 2884581 French.
-
[Implications of GABAergic synapses in neuropsychiatry].J Pharmacol. 1985;16 Suppl 2:5-27. J Pharmacol. 1985. PMID: 2867252 Review. French.
-
Glutamate alteration of glutamic acid decarboxylase (GAD) in GABAergic neurons: the role of cysteine proteases.Exp Neurol. 2008 Sep;213(1):145-53. doi: 10.1016/j.expneurol.2008.05.013. Epub 2008 May 27. Exp Neurol. 2008. PMID: 18599042
-
Neuroprotection by estradiol: a role of aromatase against spine synapse loss after blockade of GABA(A) receptors.Exp Neurol. 2007 Jan;203(1):72-81. doi: 10.1016/j.expneurol.2006.07.020. Epub 2006 Sep 26. Exp Neurol. 2007. PMID: 17005180
-
A novel mechanism for GABA synthesis and packaging into synaptic vesicles.Neurochem Int. 2009 Jul-Aug;55(1-3):9-12. doi: 10.1016/j.neuint.2009.01.020. Epub 2009 Feb 6. Neurochem Int. 2009. PMID: 19428801 Review.
Cited by
-
Downregulation of tonic GABA currents following epileptogenic stimulation of rat hippocampal cultures.J Physiol. 2006 Dec 1;577(Pt 2):579-90. doi: 10.1113/jphysiol.2006.113134. Epub 2006 Sep 21. J Physiol. 2006. PMID: 16990405 Free PMC article.
-
Ferulic acid inhibits catamenial epilepsy through modulation of female hormones.Metab Brain Dis. 2022 Dec;37(8):2827-2838. doi: 10.1007/s11011-022-01054-w. Epub 2022 Aug 6. Metab Brain Dis. 2022. PMID: 35932441
-
GABAergic neuronal precursor grafting: implications in brain regeneration and plasticity.Neural Plast. 2011;2011:384216. doi: 10.1155/2011/384216. Epub 2011 Jun 20. Neural Plast. 2011. PMID: 21766042 Free PMC article. Review.
-
Paroxysmal inhibitory potentials mediated by GABAB receptors in partially disinhibited rat hippocampal slice cultures.J Physiol. 1991 Dec;444:375-96. doi: 10.1113/jphysiol.1991.sp018884. J Physiol. 1991. PMID: 1688032 Free PMC article.
-
Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.Drugs. 1991 Jun;41(6):889-926. doi: 10.2165/00003495-199141060-00007. Drugs. 1991. PMID: 1715266 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical